BioSpace News Archive

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching, announces today its newly developed “Hub” aimed to build strategic partnerships with some of the most prominent Just-In-Time (JIT) vendors and provider clinical research teams, looking to facilitate the largest JIT oncology clinical trial network in the world.

DSFederal announced that it has expanded its long history of work supporting the National Institutes of Health through a new contract to provide a wide range of scientific and program support services, including highly qualified technical and scientific analytics experts, to the Office of Extramural Research.

XLerateHealth (XLH), an award-winning healthcare accelerator based in Louisville, KY, today announced the selection of nine startup companies to join its 2019 Louisville accelerator cohort.

Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need.

SHP for Skilled Nursing™ focuses on helping SNFs better manage quality and outcomes, supporting operational improvements and relationships with referring entities

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTCBB: MYMMF) (“MYM” or “The Company”) is pleased to announce that the Company has finalized the acquisition of 50% of BioHemp Naturals (“BioHemp”), a licensed hemp cultivator in the business of cultivating and distributing CBD-rich hemp biomass to licensed producers in Canada.

A new study published in the peer-reviewed journal Hepatology Communications finds that the multi-strain De Simone Formulation probiotic medical food may help in the dietary management of dysbiosis associated with cirrhosis by improving cognitive function, decreasing risk of falls, and improving inflammatory response

Camber Spine, a leading innovator in spine and medical technologies, today announced the implantation of their first oblique lumbar interbody fusion (OLIF) specific device from the SPIRA® family using the company’s proprietary SPIRA®-O Open Matrix OLIF, a unique, interbody fusion implant consisting of spiral support arches and Surface by Design™ technology.

CRH Medical Corporation, announces that it will participate in the 2019 Canaccord Genuity Growth Conference at the Intercontinental Hotel in Boston, Massachusetts.

Montefiore ranks as one of the nation’s best—again—in the U.S. News & World Report’s rankings for 2019-2020, placing in the top 1% of hospitals for complex specialty care in cancer, cardiology & heart surgery, neurology & neurosurgery, urology, nephrology, diabetes & endocrinology, gastroenterology & GI surgery, geriatrics and gynecology.